IROBOT CORP (IRBT)
US4627261005 - Common Stock
We assign a fundamental rating of 1 out of 10 to IRBT. IRBT was compared to 68 industry peers in the Household Durables industry. IRBT has a bad profitability rating. Also its financial health evaluation is rather negative. IRBT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year IRBT has reported negative net income.
In the past year IRBT has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: IRBT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: IRBT reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -41.53%, IRBT is not doing good in the industry: 94.03% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -155.07%, IRBT is doing worse than 92.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.53% | ||
| ROE | -155.07% | ||
| ROIC | N/A |
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 22.03%, IRBT is doing worse than 74.63% of the companies in the same industry.
In the last couple of years the Gross Margin of IRBT has declined.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.03% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
2. Health
2.1 Basic Checks
IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRBT has more shares outstanding
The number of shares outstanding for IRBT has been increased compared to 5 years ago.
IRBT has a worse debt/assets ratio than last year.
2.2 Solvency
IRBT has an Altman-Z score of 0.34. This is a bad value and indicates that IRBT is not financially healthy and even has some risk of bankruptcy.
IRBT's Altman-Z score of 0.34 is on the low side compared to the rest of the industry. IRBT is outperformed by 85.07% of its industry peers.
IRBT has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
IRBT has a Debt to Equity ratio of 1.03. This is in the lower half of the industry: IRBT underperforms 77.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.34 |
ROIC/WACCN/A
WACC10.59%
2.3 Liquidity
IRBT has a Current Ratio of 1.62. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
IRBT's Current ratio of 1.62 is on the low side compared to the rest of the industry. IRBT is outperformed by 77.61% of its industry peers.
A Quick Ratio of 1.09 indicates that IRBT should not have too much problems paying its short term obligations.
IRBT has a Quick ratio of 1.09. This is comparable to the rest of the industry: IRBT outperforms 53.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
IRBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.35%.
The Revenue for IRBT has decreased by -24.74% in the past year. This is quite bad
IRBT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.01% yearly.
EPS 1Y (TTM)-79.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-19.74%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Revenue growth Q2Q-14.07%
3.2 Future
IRBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.18% yearly.
The Revenue is expected to decrease by -0.97% on average over the next years.
EPS Next Y51.94%
EPS Next 2Y34.61%
EPS Next 3Y20.18%
EPS Next 5YN/A
Revenue Next Year-6.87%
Revenue Next 2Y-2.75%
Revenue Next 3Y-0.97%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IRBT's earnings are expected to grow with 20.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.61%
EPS Next 3Y20.18%
5. Dividend
5.1 Amount
No dividends for IRBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IROBOT CORP
NASDAQ:IRBT (4/25/2024, 1:09:09 PM)
6.71
-0.13 (-1.9%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap192.98M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.53% | ||
| ROE | -155.07% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.03% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-79.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y51.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-14.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y